EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Anaplastic Thyroid Carcinoma With Horner Syndrome and Unusual Metastasis Reveals Masked Papillary Thyroid Carcinoma Following Neoadjuvant Therapy

Zain Akhtar, Humberto López Castillo, Deepa Taneja

AACE Endocrinology and Diabetes · 2026-01 · 13 (1) · 79-82

DOI: 10.1016/j.aed.2025.09.004 ↗

Kurz gefasst

Fallbericht in der Zeitschrift AACE Endocrinology and Diabetes, 2026-01. Verfasst von Zain Akhtar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Burnett School of Biomedical Sciences, College of Medicine, Academic Health Sciences Center, University of Central Florida, Orlando, Florida. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objective: Anaplastic thyroid carcinoma (ATC) is a rare thyroid cancer that has the propensity to be hyperactive and is characterized by the dedifferentiation of follicular cells leading to pleomorphism. This report highlights a 68-year-old man's progression of ATC with an unusual presentation and secondary symptoms revealed to be masking an independent tumor cell origin residual papillary thyroid carcinoma following targeted treatment. Case Report: A 68-year-old man presenting with a history of aortic aneurysm and hyperlipidemia was referred for type 2 diabetes mellitus complications. He had a successful aneurysm repair; however, follow-up imaging revealed a thyroid mass, cystic lesions in the pancreas and liver, and extensive lymphadenopathy, and he endorsed symptoms of Horner syndrome. Fine-needle aspiration suggested ATC, and sequencing confirmed a BRAF V600E allelic variant. He began neoadjuvant BRAF/MEK inhibitor therapy to shrink the tumor and resolve metastasis. After a right thyroid lobectomy, pathology revealed a hidden non-BRAF-mutated papillary thyroid carcinoma. He is currently under multidisciplinary care and being considered for total thyroidectomy.

Discussion

Normally, comorbid thyroid malignancies arise from identical follicular sequence variants. It is unusual to observe 2 independent origins from comorbid thyroid cancers. In addition, the development of Horner syndrome from thyroid cancer, especially anaplastic, is incredibly rare.

Conclusion

This case is a unique depiction of how ATC can present despite uncharacteristic immunohistochemical markers, secondary symptoms, and hidden comorbidities. As an understudied malignancy, it is important to recognize this condition's variability to prevent increased mortality and morbidity.

Schlagwörter

Stichwörter der Autor:innen

Horner syndromeanaplastic thyroid carcinomaneoadjuvant therapypapillary thyroid cancerproto-oncogene proteins B-raf

Autor:innen und Institutionen

  • Burnett School of Biomedical Sciences, College of Medicine, Academic Health Sciences Center, University of Central Florida, Orlando, Florida.
  • Department of Health Sciences, College of Health Professions and Sciences, Academic Health Sciences Center, University of Central Florida, Orlando, Florida.
  • Department of Population Health Sciences, College of Medicine, Academic Health Sciences Center, University of Central Florida, Orlando, Florida.
  • Florida Diabetes, Thyroid, and Endocrine Center, Orlando, Florida.

Zitieren

APA

Akhtar, Z., López Castillo, H., & Taneja, D. (2026). Anaplastic Thyroid Carcinoma With Horner Syndrome and Unusual Metastasis Reveals Masked Papillary Thyroid Carcinoma Following Neoadjuvant Therapy. AACE Endocrinology and Diabetes, 13(1), 79-82. https://doi.org/10.1016/j.aed.2025.09.004

Vancouver

Akhtar Z, López Castillo H, Taneja D. Anaplastic Thyroid Carcinoma With Horner Syndrome and Unusual Metastasis Reveals Masked Papillary Thyroid Carcinoma Following Neoadjuvant Therapy. AACE Endocrinology and Diabetes. 2026;13(1):79-82. doi:10.1016/j.aed.2025.09.004

BibTeX
@article{Akhtar2026,
  author = {Akhtar, Zain and López Castillo, Humberto and Taneja, Deepa},
  title = {Anaplastic Thyroid Carcinoma With Horner Syndrome and Unusual Metastasis Reveals Masked Papillary Thyroid Carcinoma Following Neoadjuvant Therapy},
  journal = {AACE Endocrinology and Diabetes},
  year = {2026},
  volume = {13},
  number = {1},
  pages = {79--82},
  doi = {10.1016/j.aed.2025.09.004}
}
Kostenlos starten →